Pretreatment testing rates for patients with skin diseases may diverge from guidelines healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Review found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment.
This analysis of current testing patterns in the US suggests a need for future studies to explore the rationale used to determine such testing decisions.
The results are from a large cohort study that estimated the 6-month rate of infections among children with psoriasis who started treatment with ustekinumab, etanercept, or methotrexate.
Maria Schneeweiss, MD, on the Incidence of VTE in Psoriasis and Other Chronic Inflammatory Skin Diseases medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.